Issue 3/2018
Antidiabetic Medications in Heart Failure
Content (15 Articles)
The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions
Anne Pernille Ofstad, Dan Atar, Lars Gullestad, Gisle Langslet, Odd Erik Johansen
Clinical impact of oral antidiabetic medications in heart failure patients
Alberto Palazzuoli, Elena Ceccarelli, Gaetano Ruocco, Ranuccio Nuti
The impact of oral anti-diabetic medications on heart failure: lessons learned from preclinical studies
Vaia Lambadiari, George Dimitriadis, Nikolaos P. E. Kadoglou
Still sour about lactic acidosis years later: role of metformin in heart failure
William Kuan, Craig J. Beavers, Maya E. Guglin
DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics
Chayakrit Krittanawong, Andrew Xanthopoulos, Takeshi Kitai, Natalia Branis, HongJu Zhang, Marrick Kukin
Molecular and clinical roles of incretin-based drugs in patients with heart failure
Bassant Orabi, Rasha Kaddoura, Amr S. Omar, Cornelia Carr, Abdulaziz Alkhulaifi
Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors
Vasiliki Bistola, Vaia Lambadiari, George Dimitriadis, Ioannis Ioannidis, Konstantinos Makrilakis, Nikolaos Tentolouris, Apostolos Tsapas, John Parissis
Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance
Evangelos Oikonomou, Konstantinos Mourouzis, Petros Fountoulakis, Georgios Angelos Papamikroulis, Gerasimos Siasos, Alexis Antonopoulos, Georgia Vogiatzi, Sotiris Tsalamadris, Manolis Vavuranakis, Dimitris Tousoulis
SGLT2 inhibition and heart failure—current concepts
Joaquim Silva Custodio Jr, Andre Rodrigues Duraes, Marconi Abreu, Natalia Albuquerque Rocha, Leonardo Roever
Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects
Abdullah Kaplan, Emna Abidi, Ahmed El-Yazbi, Ali Eid, George W. Booz, Fouad A. Zouein
Potential impact of SGLT2 inhibitors on left ventricular diastolic function in patients with diabetes mellitus
Hidekazu Tanaka, Ken-ichi Hirata
The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus
Rabea Asleh, Mohammad Sheikh-Ahmad, Alexandros Briasoulis, Sudhir S. Kushwaha
Clinical correlates and pharmacological management of Asian patients with concomitant diabetes mellitus and heart failure
Yvonne May Fen Chia, Tiew-Hwa Katherine Teng, Chanchal Chandramouli, Jonathan Yap, Michael MacDonald, Carolyn S. P. Lam
Heart failure risk and major cardiovascular events in diabetes: an overview of within-group differences in non-insulin antidiabetic treatment
Paola Terlizzese, Fabrizio Losurdo, Massimo Iacoviello, Nadia Aspromonte
Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure
Yana Anfinogenova, Elena V. Grakova, Maria Shvedova, Kristina V. Kopieva, Alexander T. Teplyakov, Sergey V. Popov